Trinity Biotech plc

TRIB•United States

Healthcare United States In Vitro & In Vivo Diagnostic SubstancesOptions Available

Need professional-grade analysis? Visit stockanalysis.com

$0.61

-5.20%

End of day

Market Cap

N/A

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	—	-1.22	-1.07	-0.06	—	-0.68
Calmar	—	—	-1.88	-1.36	-0.06	—	-0.95
Sharpe	—	—	-0.96	-0.63	-0.03	—	-0.46
Omega	—	—	0.57	0.87	1.14	—	0.91
Martin	—	—	-2.36	-2.32	-0.09	—	-1.40
Ulcer	—	—	39.77	29.37	40.01	—	36.40

Trinity Biotech plc (TRIB) Price Performance

Trinity Biotech plc (TRIB) trades on United States in USD. The company is classified in the Healthcare sector under the In Vitro & In Vivo Diagnostic Substances industry. The stock currently trades at $0.61, down 5.20% from the previous close.

Over the past year, TRIB has traded between a low of $0.52 and a high of $1.91. The stock has lost 5.2% over this period. It is currently 68.2% below its 52-week high.

Company Info

Sector: Healthcare
Industry: In Vitro & In Vivo Diagnostic Substances
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): N/A
EBITDA: N/A
Profit Margin: N/A
EPS (TTM): N/A
Book Value: N/A

Technical Indicators

52 Week High: $3.44
52 Week Low: $0.48
50 Day MA: $0.76
200 Day MA: $0.91
Beta: N/A

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: N/A
Enterprise Value: N/A